Research progress of obesity and pancreatic diseases

doi:10.3877/cma.j.issn.2095-9605.2024.03.009

Abstract

Abstract:

The pancreas is an important metabolic and digestive organ in the human body, with both endocrine and exocrine functions. Numerous studies have confirmed the relationship between obesity and pancreatic diseases. Obesity increases the risk of type 2 diabetes, acute pancreatitis, pancreatic cancer, and poor prognosis. This review integrates the epidemiology, pathogenesis, treatment, and prognosis research of obesity-related pancreatic diseases, further discussing the therapeutic effects of weight loss surgery on pancreatic-related diseases. The aim is to provide a more comprehensive understanding of the relationship between obesity and pancreatic-related diseases for better prevention strategies.

Key words: Obesity, Type 2 diabetes mellitus, Acute pancreatitis, Chronic pancreatitis, Pancreatic cancer, Bariatric surgery.

Zilong Wu, Bing Wu, Kaisheng Yuan, Ruixiang Hu, Wah Yang, Cunchuan Wang. Research progress of obesity and pancreatic diseases[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2024, 10(03): 213-219.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2024.03.009

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2024/V10/I03/213

References 60

[12]	James DE, Stöckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance [J]. Nat Rev Mol Cell Biol, 2021, 22(11): 751-771.
[13]	Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes [J]. Diabetes, 2003, 52(1): 102-110.
[14]	Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes [J]. Clin Anat, 2007, 20(8): 933-942.
[15]	Lee Y, Hirose H, Ohneda M, et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships [J]. Proc Natl Acad Sci U S A, 1994, 91(23): 10878-10882.
[16]	Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes [J]. Biochem Soc Trans, 2008, 36(Pt 3): 348-352.
[17]	李星, 袁振芳. 肥胖型2型糖尿病的内科治疗进展 [J/CD]. 中华肥胖与代谢病电子杂志, 2016, 2(3): 133-137.
[18]	Nauck MA, Meier JJ. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions [J]. Lancet Diabetes Endocrinol, 2016, 4(6): 525-536.
[19]	Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial [J]. J Clin Endocrinol Metab, 2020, 105(3): 866-876.
[20]	Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review [J]. JAMA, 2020, 324(9): 879-887.
[21]	Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes [J]. N Engl J Med, 2017, 376(7): 641-651.
[22]	Gómez-Huelgas R. Bariatric surgery versus conventional medical therapy for type 2 diabetes [J]. Rev Clin Esp, 2012, 212(9): 461.
[23]	汪波, 杨丽洁, 杨张朔, 等. 3D腹腔镜Roux–en–Y胃旁路术与袖状胃切除术治疗肥胖症合并2型糖尿病临床疗效的比较 [J]. 中华实验外科杂志, 2019, 36(1): 134-137．
[24]	Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2021 [J]. Gastroenterology, 2022, 162(2): 621-644.
[25]	Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis [J]. Curr Opin Gastroenterol, 2017, 33(5): 374-382.
[26]	Hansen SEJ, Madsen CM, Varbo A, et al. Body mass index, triglycerides, and risk of acute pancreatitis: a population-based study of 118 000 individuals [J]. J Clin Endocrinol Metab, 2020, 105(1): 163-174.
[27]	Yang X, He J, Ma S, et al. The role of comorbid hypertriglyceridemia and abdominal obesity in the severity of acute pancreatitis: a retrospective study [J]. Lipids Health Dis, 2021, 20(1): 171.
[28]	Maatman TK, Roch AM, Ceppa EP, et al. The continuum of complications in survivors of necrotizing pancreatitis [J]. Surgery, 2020, 168(6): 1032-1040.
[29]	McGuire SP, Keller SL, Maatman TK, et al. Obesity worsens local and systemic complications of necrotizing pancreatitis and prolongs disease course [J]. J Gastrointest Surg, 2022, 26(10): 2128-2135.
[30]	Thavamani A, Umapathi KK, Roy A, et al. The increasing prevalence and adverse impact of morbid obesity in paediatric acute pancreatitis [J]. Pediatr Obes, 2020, 15(8): e12643.
[31]	Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity [J]. Sci Transl Med, 2011, 3(107): 107ra110.
[32]	Lim J, Wirth J, Wu K, et al. Obesity, adiposity, and risk of symptomatic gallstone disease according to genetic susceptibility [J]. Clin Gastroenterol Hepatol, 2022, 20(5): e1083-e1120.
[33]	Lammert F, Gurusamy K, Ko CW, et al. Gallstones [J]. Nat Rev Dis Primers, 2016, 2: 16024.
[34]	Wang K, Zhao A, Tayier D, et al. Activation of AMPK ameliorates acute severe pancreatitis by suppressing pancreatic acinar cell necroptosis in obese mice models [J]. Cell Death Discov, 2023, 9(1): 363.
[35]	Xiao C, Dash S, Morgantini C, et al. New and emerging regulators of intestinal lipoprotein secretion [J]. Atherosclerosis, 2014, 233(2): 608-615.
[36]	Premkumar R, Phillips AR, Petrov MS, et al. The clinical relevance of obesity in acute pancreatitis: targeted systematic reviews [J]. Pancreatology, 2015, 15(1): 25-33.
[37]	Pellegrini J, Sodoma AM, Munshi R, et al. Impact of obesity on outcomes associated with acute alcoholic pancreatitis [J]. Cureus, 2024, 16(1): e51653.
[38]	Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition [J]. Pancreatology, 2016, 16(2): 218-224.
[39]	Beyer G, Habtezion A, Werner J, et al. Chronic pancreatitis [J]. Lancet, 2020, 396(10249): 499-512.
[40]	Gupte A, Goede D, Tuite R, et al. Chronic pancreatitis [J]. BMJ, 2018, 361: k2126.
[41]	Vege SS, Chari ST. Chronic Pancreatitis [J]. N Engl J Med, 2022, 386(9): 869-878.
[42]	Sreedhar UL, DeSouza SV, Park B, et al. A systematic review of intra-pancreatic fat deposition and pancreatic carcinogenesis [J]. J Gastrointest Surg, 2020, 24(11): 2560-2569.
[43]	He J, Ahuja N, Makary MA, et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades [J]. HPB (Oxford), 2014, 16(1): 83-90.
[1]	Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee [R]. World Health Organ Tech Rep Ser, 1995, 854: 1-452.
[2]	NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults [J]. Lancet, 2017, 390(10113): 2627-2642.
[3]	Gordon-Larsen P, French JE, Moustaid-Moussa N, et al. Synergizing mouse and human studies to understand the heterogeneity of obesity [J]. Adv Nutr, 2021, 12(5): 2023-2034.
[4]	GBD 2015 Obesity Collaborators; Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years [J]. N Engl J Med, 2017, 377(1): 13-27.
[5]	Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss [J]. Int J Obes (Lond), 2015, 39(3): 480-487.
[6]	Alsamarrai A, Das SL, Windsor JA, et al. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies [J]. Clin Gastroenterol Hepatol, 2014, 12(10): 1635-U99.
[7]	Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation [J]. J Endocrinol, 2014, 222(3): R113-R127.
[8]	Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases [J]. Circ Res, 2020, 126(11): 1477-1500.
[9]	Gostoli S, Raimondi G, Popa AP, et al. Behavioral lifestyle interventions for weight loss in overweight or obese patients with type 2 diabetes: a systematic review of the literature [J]. Curr Obes Rep, 2024, 13(2): 224-241.
[10]	Inaishi J, Saisho Y. Beta-Cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: a mini-review [J]. Nutrients, 2020, 12(12): 3846.
[11]	Lotta LA, Gulati P, Day FR, et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance [J]. Nat Genet, 2017, 49(1): 17-26.
[44]	Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer [J]. JAMA, 2001, 286(8): 921-929.
[45]	Babic A, Bao Y, Qian ZR, et al. Pancreatic cancer risk associated with prediagnostic plasma levels of leptin and leptin receptor genetic polymorphisms [J]. Cancer Res, 2016, 76(24): 7160-7167.
[46]	Chung KM, Singh J, Lawres L, et al. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma [J]. Cell, 2020, 181(4): 832-847.
[47]	Halbrook CJ, Lyssiotis CA. Employing metabolism to improve the diagnosis and treatment of pancreatic cancer [J]. Cancer Cell, 2017, 31(1): 5-19.
[48]	Zhang C, Liu J, Liang Y, et al. Tumour-associated mutant p53 drives the Warburg effect [J]. Nat Commun, 2013, 4: 2935.
[49]	Ying H, Kimmelman AC, Lyssiotis CA, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism [J]. Cell, 2012, 149(3): 656-670.
[50]	Bryant KL, Mancias JD, Kimmelman AC, et al. KRAS: feeding pancreatic cancer proliferation [J]. Trends Biochem Sci, 2014, 39(2): 91-100.
[51]	Qin C, Yang G, Yang J, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies [J]. Mol Cancer, 2020, 19(1): 50.
[52]	Chung YT, Matkowskyj KA, Li H, et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma [J]. Mod Pathol, 2012, 25(5): 758-766.
[53]	Kong D, Wu Y, Tong B, et al. CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10 [J]. Biochim Biophys Acta Mol Basis Dis, 2024, 6: 167214.
[54]	Ding Y, Mullapudi B, Torres C, et al. Omega-3 fatty acids prevent early pancreatic carcinogenesis via repression of the AKT pathway [J]. Nutrients, 2018, 10(9): 1289.
[55]	Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort[J]. Ann Surg, 2019, 269(1): 95-101.
[56]	Hui SCN, Wong SKH, Ai Q, et al. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI [J]. Eur Radiol, 2019, 29(2): 849-856.
[57]	Honka H, Koffert J, Hannukainen JC, et al. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow [J]. J Clin Endocrinol Metab, 2015, 100(5): 2015-2023.
[58]	韩莹, 齐向秀, 刘丽娜. Roux-en-Y胃旁路术与袖状胃切除术治疗反复肥胖型急性高脂血症性胰腺炎的临床比较 [J/CD]. 中华普外科手术学杂志(电子版), 2021, 15(03): 347-350.
[59]	Méndez-Giménez L, Becerril S, Camões SP, et al. Role of aquaporin-7 in ghrelin- and GLP-1-induced improvement of pancreatic β-cell function after sleeve gastrectomy in obese rats [J]. Int J Obes (Lond), 2017, 41(9): 1394-1402.
[60]	Vujasinovic M, Valente R, Thorell A, et al. Pancreatic exocrine insufficiency after bariatric surgery [J]. Nutrients, 2017, 9(11): 1241.

Please choose a citation manager

Content to export